Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA1 | P42261 | 1/20 | 0.36 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.36 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.36 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.33 |
| ▸ | PDXK | O00764 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.32 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.32 |
| ▸ | CASP6 | P55212 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2512345 | 1.00 | GRIA1 (0.36) | GRIA1GRIA2GRIA3GRIA4LMNA | |
| Cytosine SCHEMBL23783515 | 0.83 | ADORA2A (0.32) | TYMS | |
| SCHEMBL31685244 | 0.72 | TYMS (0.43) | GRIA1GRIA2GRIA3GRIA4LMNA | |
| SCHEMBL18962198 | 0.72 | KDM4E (0.33) | GRIA1GRIA2GRIA3GRIA4LMNA | |
| Flucytosine SCHEMBL24064 | 0.68 | — | — | |
| SCHEMBL30510082 | 0.68 | — | — | |
| SCHEMBL213586 | 0.68 | — | — | |
| SCHEMBL7161858 | 0.68 | — | — | |
| SCHEMBL29551741 | 0.65 | ABL1 (0.32) | LMNAKDM4EALDH1A1KMT2AHSD17B10 | |
| SCHEMBL24549964 | 0.65 | CHEK1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 12294 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146294-A1 | METHODS TO ENRICH NUCLEOTIDE VARIANTS BY NEGATIVE SELECTION | GUARDANT HEALTH, INC. (US) | 2026-05-28 | — | — | US | claimed |
| US-12637489-B2 | Silicon containing modified nucleotide analogs | Singular Genomics Systems, Inc. (US) | 2026-05-26 | — | — | US | claimed |
| WO-2026106497-A2 | FUNCTIONALIZED CIRCULAR RNA AND METHODS AND INTERMEDIATES FOR THEIR PRODUCTION | SIEĆ BADAWCZA ŁUKASIEWICZ – PORT POLSKI OSRODEK ROZWOJU TECHNOLOGII (PL) | 2026-05-21 | — | — | WO | claimed |
| US-12630866-B2 | Methods for analyzing nucleic acids | BIOMODAL LIMITED (GB) | 2026-05-19 | — | — | US | claimed |
| WO-2026102107-A1 | METHODS FOR DETECTING SOMATIC VARIANTS | GUARDANT HEALTH, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| CN-122038534-A | Construction method of DNA library with modified nucleotide and application thereof | 深圳华大智造科技股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026102110-A1 | INDIVIDUALIZED MRD ASSAY TYPE SELECTION TO MAXIMIZE PER PATIENT SENSITIVITY BASED ON COMPREHENSIVE TUMOR VARIANT PROFILING | GUARDANT HEALTH, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| CN-122029177-A | Oligonucleotides containing multiple ligands and/or lipids | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122029176-A | Containing a plurality of oligonucleotides modified oligonucleotides | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122028913-A | Oligonucleotides containing ligands in nucleobases, 2 'or 3' positions | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| WO-1998029124-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR THE MODULATION OF THE EXPRESSION OF B7 PROTEIN | ISIS PHARMACEUTICALS, INC. (US) | 1998-07-09 | — | — | WO | claimed |
| US-5160725-A | Contrast agent for diagnostic imaging, polyethylene glycol phosphates and carboxylates as stabilizers | SILICA GEL GESELLSCHAFT MBH ADSORPTIONS-TECHNIK, APPARATEBAU (DE) | 1992-11-03 | — | — | US | claimed |
| EP-0173251-B1 | NUCLEIC-ACIDS SEQUENCE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE DETERMINATION OF NUCLEIC ACIDS | Roche Diagnostics GmbH (DE) | 1989-11-23 | — | — | EP | claimed |
| WO-1989002475-A1 | POLYALDEHYDIC POLYNUCLEOTIDES IN USE AS PROBES, THEIR PREPARATION AND USE | MATTSON THOMAS LEE (US) | 1989-03-23 | — | — | WO | claimed |
| EP-0122151-B1 | PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1989-02-15 | — | — | EP | claimed |
| US-4783402-A | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1988-11-08 | — | — | US | claimed |
| EP-0122151-A2 | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1984-10-17 | — | — | EP | claimed |
| US-4115576-A | 5-HYDROXYMETHYLCYTOSINE, A B6 VITAMIN, NICOTINAMIDE OR NICOTINIC ACID | PENN NATHAR W | 1978-09-19 | — | — | US | claimed |
| US-4048316-A | Composition for antagonizing the narcotic effects of barbiturate addiction and withdrawal effects, and for treatment of barbiturate poisoning | PENN NATHAR W | 1977-09-13 | — | — | US | claimed |
| US-4029768-A | Composition for application to the animal brain for synthesis of brain components involved in the learning process, and method | PENN NATHAR W | 1977-06-14 | — | — | US | claimed |